Read + Share
Park K, Chang GC, Curigliano G, Lim WT, et al. Phase I results of S49076 plus gefitinib in patients with EGFR TKI-resistant
non-small cell lung cancer harbouring MET/AXL dysregulation. Lung Cancer 2021;155:127-135.
PMID: 33798902
|
 |
|
Park K, Chang GC, Curigliano G, Lim WT, et al. Phase I results of S49076 plus gefitinib in patients with EGFR TKI-resistant
non-small cell lung cancer harbouring MET/AXL dysregulation. Lung Cancer 2021;155:127-135.
PMID: 33798902
|
|
|
|